Journal of NeuroVirology

, Volume 8, Issue 3, pp 158–167

Central nervous system infections in individuals with HIV-1 infection

  • Arunima Mamidi
  • Joseph A. DeSimone
  • Roger J. Pomerantz
Review

Abstract

Opportunistic infections of the central nervous system (CNS) are common complications of advanced immunodeficiency in individuals with human immunodeficiency virus type 1 (HIV-1) infection. Neurological disease is the first manifestation of acquired immunodeficiency syndrome (AIDS) in 10% to 20% of symptomatic HIV-1 infection. Prompt diagnosis and treatment of such disorders is critical. Also, in the era of highly active antiretroviral therapy (HAART), these disease states have changed in presentation and epidemiology. Therefore, we review the epidemiology, pathogenesis, clinical features, diagnosis, and management of five common central nervous system disorders in individuals with HIV-1 infection: toxoplasma encephalitis, primary central nervous system lymphoma, cryptococcal meningitis, cytomegalovirus encephalitis, and progressive multifocal leukoencephalopathy.

Keywords

human immunodeficiency virus type 1 toxoplasma encephalitis cryptococcal meningitis cytomegalovirus encephalitis progressive multifocal leukoencephalopathy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998). HAART significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12: 1149–1154.PubMedCrossRefGoogle Scholar
  2. Antinori A, Cingolani A, De Luca A, Gaidano G, Ammassari A, Larocca L, Ortona L (1999). Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Ann Neurol 5: 259–261.CrossRefGoogle Scholar
  3. Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA (1995a). Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Micro 33: 1580–1583.Google Scholar
  4. Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA (1995b). Level of CMV DNA in cerebrospinal fluid of subjects with AIDS and CMV infection in the central nervous system. J Infect Dis 172: 527–531.PubMedCrossRefGoogle Scholar
  5. Astrom KE, Mancall EL, Richardson EP (1958). Progressive multifocal leukoencephalopathy. Brain 81: 92–111.CrossRefGoogle Scholar
  6. Berger JR, Kaszovitz B, Post J, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87.PubMedCrossRefGoogle Scholar
  7. Berger JR, Mucke L (1988). Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurol 38: 1060–1065.CrossRefGoogle Scholar
  8. Berger JR, Pall L, Lanska D, Whiteman M (1998). Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neuro Virol 4: 59–68.Google Scholar
  9. Berman SM, Kim RC (1994). The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir. Am J Med 96: 415–419.PubMedCrossRefGoogle Scholar
  10. Brambilla AM, Castagna A, Novati R, Cinque P, Terreni MR, Moioli MC, Lazzarin A (1999). Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy. J Neurology 246: 723–725.CrossRefGoogle Scholar
  11. Chamberlain M, Kormanik P (1999). AIDS-related central nervous system lymphomas. J NeuroOncol 43: 269–276.PubMedCrossRefGoogle Scholar
  12. Chang L, Miller B, McBride D, Cornford M, Oropilla G, Buchtal S, Chiang F, Aronow H, Beck CK, Ernst T (1995). Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 197: 525–531.PubMedGoogle Scholar
  13. Chowdhury M, Kundu M, Khalili K (1993). GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCV, in cells derived from central nervous system. Oncogene 8: 887–892.PubMedGoogle Scholar
  14. Cingolani A, De Luca A, Ammassari A, Murri R, Linzalone A, Grillo R, Antinori A (1996). PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions. J Med Microbiol 45: 472–476.PubMedCrossRefGoogle Scholar
  15. Cingolani A, De Luca A, Larocca L, Ammassari A, Scerrati M, Antinori A, Ortona L (1998). Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 90: 364–369.PubMedCrossRefGoogle Scholar
  16. Cinque P, Baldanti F, Vago L, Terreni M, Lillo F, Furione M, Castagna A, Monforte A, Lazzarin A, Linde A (1995). Ganciclovir therapy for cytomegalovirus infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis 171: 1603–1606.PubMedCrossRefGoogle Scholar
  17. Cinque P, Vago L, Dahl H, Brytting M, Terreni M, Fornara C, Racca S, Castagna A, Monforte A, Wahren B, Lazzarin A, Linde A (1996). Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10: 951–958.PubMedCrossRefGoogle Scholar
  18. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, van Loon A, Klapper P (1998). Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. J Neuro Virol 4: 120–132.Google Scholar
  19. Clifford DB, Arribas JR, Storch GA, Tourtellote W, Wippold FJ (1996). Magnetic resonance brain imaging lacks sensitivity for AIDS associated cytomegalovirus encephalitis. J Neuro Virol 2: 397–403.Google Scholar
  20. Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.PubMedCrossRefGoogle Scholar
  21. Cohen B (1999). Neurologic manifestations of toxoplasmosis in AIDS. Semin Neurol 19: 201-.PubMedCrossRefGoogle Scholar
  22. Corn B, Donhaue B, Rosenstock J, Hyslop T, Brandon A, Hegde H, Cooper J, Sherr D, Fisher S, Berson A, Han H, Abdel-Wahab M, Koprowski C, Ruffer J, Curran W (1997). Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience. Cancer J Sci Am 3: 52–56.PubMedGoogle Scholar
  23. Dannemann B, McCutchan A, Israelski D, Antoniskis D, Leport C, Luft B, Nussbaum J, Clumeck N, Morlat P, Chiu J, Vilde J, Orellana M, Feigal D, Bartok A, Heseltine P, Leedom J, Remington J (1992). Treatment of toxoplasmic encephalitis in patients with AIDS. Ann of Intern Med 116: 33–43.CrossRefGoogle Scholar
  24. DeLuca A, Cingolani A, Linzalone A, Ammassari A, Murri R, Giancola M, Maiuro G, Antinori A (1996). Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J Clin Micro 34: 1343–1346.Google Scholar
  25. DeLuca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virolgical monitoring during treatment with intathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.CrossRefGoogle Scholar
  26. DeLuca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia M, Govoni A, Murri R, Testa L, Monforte A, Antinori A (2000). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 14: 117–121.CrossRefGoogle Scholar
  27. Dworkin MS, Wan PC, Hanson DL, Jones JL, Adult and Adolescent Spectrum of HIV Disease Project (1999). Progressive multifocal leukoencephalopathy: improved survival of HIV-infected patients in the protease inhibitor era. J Infect Dis 180: 621–625.PubMedCrossRefGoogle Scholar
  28. Ferrante P, Calderelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G (1995). PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy. J Med Virol 47: 219-.PubMedCrossRefGoogle Scholar
  29. Fessier RD, Sobel J, Guyot L, Crane L, Vazguez J, Szuba M, Diaz F (1998). Management of elevated intracranial pressure in patients with cryptococcal meningitis. J AIDS Human Retrovirol 17: 137–142.Google Scholar
  30. Fine H, Mayer R (1993). Primary central nervous system lymphoma. Ann Intern Med 119: 1093–1104.PubMedCrossRefGoogle Scholar
  31. Flinn I, Ambinder R (1996). AIDS primary central nervous system lymphoma. Curr Opin Oncol 8: 373–376.PubMedCrossRefGoogle Scholar
  32. Fong IW, Toma E, Canadian PML Study Group (1995). The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 20: 1305–1310.PubMedCrossRefGoogle Scholar
  33. Friedman PD, Samore MH, Kraemer KL, Calkins DR (1995). Clinical correlates of secondary meningitis in HIV-infected adults. Arch Intern Med 155: 2231–2237.CrossRefGoogle Scholar
  34. Furrer H, Opravil M, Bernasconi E, Telenti A, Egger M (2000). Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Lancet 355: 2217–2218.PubMedCrossRefGoogle Scholar
  35. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE, zidovudine epidemiology group (1992). Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 166: 1223–1227.PubMedCrossRefGoogle Scholar
  36. Hall CD, Dafni U, Simpson D, Clifford D, Wetherill P, Cohen B, McArthur J, Hollander H, Yiannoutsos C, Major E, Millar L, Timpone J (1998). Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 338: 1345–1351.PubMedCrossRefGoogle Scholar
  37. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM (1994). Exogenous tat protein activates central nervous system-derived endothelial cells. J Neuroimmunol 54: 19–28.PubMedCrossRefGoogle Scholar
  38. Holland NR, Power C, Mathews VP, Glass JD, Forman M, McArthur JC (1994). Cytomegalovirus encephalitis in AIDS. Neurology 44: 507–514.PubMedCrossRefGoogle Scholar
  39. Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC (1991). Epidemiology of progressive multifocal leukoencephalopathy in the United States. Neurology 41: 1733–1736.PubMedCrossRefGoogle Scholar
  40. Kalayjian RC, Cohen ML, Bonomo RA, Flanigan TP (1993). Cytomegalovirus ventriculoencephalitis in AIDS. Medicine 72: 67–77.PubMedCrossRefGoogle Scholar
  41. Koralnik IJ, Pasquier RA, Letvin NL (2001). JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol 75: 3483–3487.PubMedCentralPubMedCrossRefGoogle Scholar
  42. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J (1985). Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 17: 344–349.PubMedCrossRefGoogle Scholar
  43. Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim K, Hirano A, Dickson D (1991). Human immunodeficiency virus-1 infection of the nervous system. Hum Pathol 22: 700–710.PubMedCrossRefGoogle Scholar
  44. Laurenson IF, Ross JC, Milne JR (1997). Microscopy and latex antigen negative cryptococcal meningitis. J Infect 36: 329–331.CrossRefGoogle Scholar
  45. Leenders A, Reiss P, Portegies P, Clezy K, Hop W, Hoy J, Borleffs J, Allworth T, Kauffmann R, Jones P, Kroon F, Verbrugh H, de Marie S (1997). Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11: 1463–1471.PubMedCrossRefGoogle Scholar
  46. Levy R, Rothholtz V (1997). HIV-1-related neurologic disorders. Neuroimag Clin North Am 7: 527–547.Google Scholar
  47. Luft B, Remington J (1992). Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15: 211–222.PubMedCrossRefGoogle Scholar
  48. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR (1992). Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Micro Rev 5: 49–73.PubMedGoogle Scholar
  49. Marra CM, Rajicic N, Barker DE, Cohen B, Clifford D, ACTG 363 team (2001). Prospective pilot study of cidofovir for HIV-associated progressive multifocal leukoencephalopathy. 8th Conf Retro and Opp Infect, Abstract 596.Google Scholar
  50. Martinez E, Garcia-Viejo M, Marcos M, Perez-Cuevas J, Blanco J, Mallolas J, Miro J, Gatell J (2000). Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. AIDS 14: 2615–2617.PubMedCrossRefGoogle Scholar
  51. McCutchan JA (1995). Clinical impact of cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 21(Suppl 2): S196-S201.PubMedCrossRefGoogle Scholar
  52. McGowan J, Shah S (1998). Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 12: 952–953.PubMedGoogle Scholar
  53. Monaco MC, Jensen PN, Hou J, Durham LC, Major EO (1998). Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 72: 918–923.Google Scholar
  54. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK (1987). Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome. Hum Pathol 18: 289–297.PubMedCrossRefGoogle Scholar
  55. Murray H (1999). Toxoplasmosis. In AIDS Therapy. Dolin R, Masur H, Saag M (eds). New York: Churchill Livingstone, pp 307–327.Google Scholar
  56. Oursler K, Moore R, Chaisson R (1999). Risk factors for cryptococcal meningitis in HIV-infected patients. AIDS Res Human Retrovir 15: 625–631.CrossRefGoogle Scholar
  57. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ (1971). Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1: 1257–1260.PubMedCrossRefGoogle Scholar
  58. Perrons CJ, Fox JD, Lucas SB, Brink NS, Tedder RS, Miller RF (1996). Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. J Infect 32: 205–209.PubMedCrossRefGoogle Scholar
  59. Petito CK, Cho ES, Lemann W, Navia BA, Price RW (1986). Neuropathology of acquired immunodeficiency syndrome: an autopsy review. J Neuropathol Exp Neurol 45: 635–646.PubMedCrossRefGoogle Scholar
  60. Pierce M, Johnson M, Maciunas R, Murray M, Allen G, Harbison M, Creasy J, Kessler R (1995). Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography. Ann Intern Med 123: 594–598.PubMedCrossRefGoogle Scholar
  61. Potasman I, Resnick L, Luft B, Remington J (1988). Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108: 49–51.PubMedCrossRefGoogle Scholar
  62. Power C, Kong PA, Crawford TO, Wesselingh S, Glass J, McArthur J, Trapp B (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood—brain barrier. Ann Neurol 34: 339–350.PubMedCrossRefGoogle Scholar
  63. Price TA, Digioia RA, Simon GL (1992). Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis 15: 606–608.PubMedCrossRefGoogle Scholar
  64. Price D, Klein J, Fisher M, Main J, Bingham J, Coker R (1997). Potential role for granulocyte-macrophage colony-stimulating factor in the treatment of HIV-associated cryptococcal meningitis. AIDS 11: 693–694.PubMedCrossRefGoogle Scholar
  65. Raez L, Patel P, Feun L, Restrepo A, Raub W, Cassileth P (1998). Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Crit Rev Oncol 9: 199–208.Google Scholar
  66. Renold C, Sugar A, Chave J, Perrin L, Delavelle J, Pizzolato G, Burkhard P, Gabriel V, Hirschel B (1992). Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 71: 224–239.PubMedCrossRefGoogle Scholar
  67. Roberts T, Storch G (1997). Multiplex PCR for diagnosis of AIDS-related central nervous system lymphoma and toxoplasmosis. J Clin Microbiol 35: 268–269.PubMedCentralPubMedGoogle Scholar
  68. Ruiz A, Post J, Bundschu C, Ganz W, Georgiou M (1997). Primary central nervous system lymphoma in patients with AIDS. Neuroimag Clin North Am 7: 281–296.Google Scholar
  69. Saag M, Cloud G, Graybill R, Sobel J, Tuazon C, Johnson P, Fessel W, Moskovitz B, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes W (1999). A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 28: 291–296.PubMedCrossRefGoogle Scholar
  70. Saag M, Graybill R, Larsen R, Pappas P, Perfect J, Powderly W, Sobel J, Dismukes W (2000). Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 30: 710–718.PubMedCrossRefGoogle Scholar
  71. Saba J, Morlat P, Raffi F, Hazebroucq V, Joly V, Leport C, Vilde J (1993). Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. Eur J Clin Microbiol Infect Dis 12: 853–856.PubMedCrossRefGoogle Scholar
  72. Sadler M, Brink N, Gazzard B (1998a). Management of intracerebral lesions in patients with HIV: a retrospective study with discussion of diagnostic problems. Q J Med 91: 205–217.CrossRefGoogle Scholar
  73. Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG (1998b). New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients. AIDS 12: 533–535.PubMedGoogle Scholar
  74. Salazar A, Podzamczer D, Rene R, Santin M, Perez J, Ferrer I, Fernandez-Viladrich P, Gudiol F (1995). Cytomegalovirus ventriculoencephalitis in AIDS patients. Scand J Infect Dis 27: 165–169.PubMedCrossRefGoogle Scholar
  75. Sanchez-Portocarrero J, Perez-Cecilia E (1997). Intracerebral mass lesions in patients with human immunodefeciency virus infection and cryptococcal meningitis. Diagn Microbiol Infect Dis 29: 193–198.PubMedCrossRefGoogle Scholar
  76. Silber E, Sonnenberg P, Koornhof H, Morris L, Saffer D (1998). Dual infective pathology in patients with cryptococcal meningitis. Amer Acad of Neurol 51: 1213–1215.Google Scholar
  77. Simpson D, Tagliati M (1994). Neurologic manifestation of HIV infection. Ann Intern Med 121: 769–785.PubMedCrossRefGoogle Scholar
  78. Slobod K, Taylor G, Sandlund J, Furth P, Helton K, Sixbey J (2000). Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet 356: 1493–1494.PubMedCrossRefGoogle Scholar
  79. Sparano J (1995). Treatment of AIDS-related lymphomas. Curr Opin Oncol 7: 442–449.PubMedCrossRefGoogle Scholar
  80. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K (1990). Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479–3483.PubMedCrossRefGoogle Scholar
  81. Taoufik Y, Gasnault J, Karaterki A, Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy J, Dussoix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 178: 1816–1820.PubMedCrossRefGoogle Scholar
  82. Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E, Costagliola D (1999). Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 13: 1881–1887.PubMedCrossRefGoogle Scholar
  83. Thorner A, Katz J (2001). Progressive multifocal leukoencephalopathy. Curr Infect Dis Rep 3: 352–359.PubMedCrossRefGoogle Scholar
  84. Tornatore C, Berger JR, Houff SA, Curfman B, Meyers K, Winfield D, Major E (1992). Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 31: 454–462.PubMedCrossRefGoogle Scholar
  85. Vago L, Cinque P, Sala E, Nebuloni M, Caldarelli R, Racca S, Ferrante P, Trabattoni G, Costanzi G (1996). JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. J AIDS 12: 139–146.Google Scholar
  86. Vinters HV, Kwok MK, Ho HW, Anders K, Tomiyasu U, Wolfson W, Robert F (1989). Cytomegalovirus in the nervous system of patients with acquired immunodeficiency syndrome. Brain 112: 245–268.PubMedCrossRefGoogle Scholar
  87. Walot I, Miller BL, Chang L, Mehringer CM (1996). Neuroimaging findings in patients with AIDS. Clin Infect Dis 22: 906–919.PubMedCrossRefGoogle Scholar
  88. Weber T, Turner R, Frye S, Ruf B, Haas J, Schielke E, Pohle H, Luke W, Luer W, Felgenhauer K, Hunsmann G (1994). Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 169: 1138–1141.PubMedCrossRefGoogle Scholar
  89. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP (1993). Progressive mutifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187: 233–240.PubMedGoogle Scholar
  90. Wiselka MJ, Read R, Finch RG (1996). Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. J Infection 33: 227–229.CrossRefGoogle Scholar
  91. Woods M, MacGinley R, Eisen D, Allworth A (1998). HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12: 1491–1494.PubMedCrossRefGoogle Scholar
  92. Wright D, Schneider A, Berger J (1997). Central nervous system opportunistic infections. Neuroimag Clin North Am 7: 513-.Google Scholar
  93. Yiannoutsos CT, Major EO, Curfman B, Jensen P, Gravell M, Hou J, Clifford D, Hall C (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45: 816–819.PubMedCrossRefGoogle Scholar
  94. Zeind C, Cleveland K, Menon M, Brown J, Solomon D (1996). Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. Pharmacotherapy 16: 547–561.PubMedGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2002

Authors and Affiliations

  • Arunima Mamidi
    • 1
  • Joseph A. DeSimone
    • 1
  • Roger J. Pomerantz
    • 1
  1. 1.Division of Infectious Diseases, Department of Medicine, Jefferson Medical CollegeThomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations